The European Community and Biodiversity Loss: Missing the Target?

The European Community has set itself the stringent policy target of halting all biodiversity loss by 2010. It intends to achieve this target by following a dual strategy. On the one hand, the 1979 Wild Birds Directive and 1992 Habitats Directive are designed to protect important sites housing vulnerable wildlife. On the other hand, biodiversity protection is to be integrated into all other Community policies. The Community views the Common Agricultural Policy as having a vital role in both areas. It provides a mechanism through which much needed Community funding can be channelled into the management of protected wildlife sites. Equally, it also has an important influence upon biodiversity in the wider countryside. This article examines the regulatory measures that have been taken to integrate biodiversity protection into the Community's agricultural policies and assesses whether they are likely to be sufficient to enable the Community to meet its 2010 target.     

Innovations and intellectual property: the case of genomic patenting.

In an effort to balance static and dynamic efficiency in the production and use of knowledge, societies institute intellectual property policies. In the United States, the patent system is a well-established mechanism to provide inventors with time-limited protection of new technologies in exchange for disclosure of information about their inventions. Emerging biotechnology, specifically the filing of patents on gene sequences, raises serious questions about whether the patent system is appropriately weighing societal costs and benefits in its grants of intellectual property protection. Gene sequences represent a hybrid case between discrete inventions and more general pieces of information that are useful for many, potentially very different, purposes. This information content in genes makes it possible for a patent on a gene to cover a wide range of possible technological applications and, as a result, be of unknown breadth when issued. This analysis explores the potential effect of these characteristics on future innovation in biotechnology. Copyright 2003 by the Association for Public Policy Analysis and Management.     

Genomic research and incidental findings.

The Human Genome Project showed that there is significant genetic variation within the population. Current research is accumulating large databases that may reveal genetic variations associated with disease or health risks, even if not intended as part of the study design. These incidental findings create legal, ethical, and financial challenges for researchers. Current federal and international guidelines are not adequate. Plans for dealing with incidental findings need to be established in the study design and reviewed and approved by the Institutional Review Board.     

Conflict Between Doctor and Patient

"The belief that doctors can act on behalf of patients denies the existence of inevitable conflict." Jay Katz¹     

Alienation-reduction as a paradigm for delinquency reduction

It is suggested that agencies adopt the concept of alienation-reduction as the paradigm for designing and coordinating juvenile delinquency programs. Existing theory and data are consistent with the view that delinquency is associated with alienation and most existing rehabilitation approaches can be viewed within the framework of alienation-reduction. Adoption of the paradigm offers three important advantages: (1) it defines the problem in terms of the individual's relation to his environment; (2) it can facilitate communication among diverse youth-serving agencies; (3) it provides a logical basis for action and decisions regarding prevention, diversion, and treatment programs.     

Effects of inconsistent eyewitness statements on mock-jurors' evaluations of the eyewitness,perceptions of defendant culpability and verdicts

In attempting to discredit an eyewitness, it is a common strategy for an attorney to highlight inconsistencies in the eyewitness's recall testimony during cross-examination and encourage the jurors to infer, based on those inconsistencies, that the eyewitness's memory is faulty. An experiment was conducted to examine the effectiveness of this cross-examination strategy. Subjects viewed a simulated cross-examination and rendered judgmenets about the eyewitness and defendant. The type of inconsistent testimony was manipulated between subjects. Subjects exposed to inconsistent recall testimony about either central or peripheral details perceived the eyewitness as less credible (as evidenced by ratings on multiple dimensions) and the defendant as less culpable. Inconsistency on central details led to fewer convictions. Results point to the effectiveness of this cross-examination strategh.